Académique Documents
Professionnel Documents
Culture Documents
Director
PRIME INSTITUTE OF MEDICAL EDUCATION
(Website: www.primepg.org )
Contact numbers: +91 - 8586996883, 8586996894.
■ #Mechanism_of_TRALI:
Donor anti HLA-I and HLA-II antibodies will activate neutrophil within recipient's
body, which will cause sequestration of activated neutrophils within the pulmonary
capillaries, leading to acute lung injury by releasing inflammatory mediators like
cytokines....
Adipokines:
-----------------------
*Adipose tissue acts as a functional endocrine organ. It secrets variety of proteins
into the systemic circulation, which are termed adipokines (or adipose cytokines).
Carcinoid:
• Most common site for carcinoid is GIT>>> Lungs.
• Most common site for carcinoid in GIT is Appendix (38%)>>> Small
intestine (29%).
References:
a) Devitas Oncology 10/e page 553
b) Sabiston 20/e page 1272
a) Appendix (38%),
b) Small intestine (29%),
c) Colon (13%),
d) Stomach (12%), and
e) Rectum (8%).
• The changes in these distributions are associated with the increased
incidence of NETs along with the changes of the World Health Organization
classification of these tumors in 2010.
• The malignant potential (ability to metastasize) is related to location, size,
depth of invasion, and growth pattern.
a) Only approximately 3% of appendiceal NETs metastasize, but
b) About 35% of ileal NETs are associated with metastasis.
**********************************************************
*****
Diagnosis of AML:
( Ref—wintrobe 13/e page ---1548..)
■ For most cases of AML, blast cell count >20% or more in either Peripheral
Blood or bone marrow is necessary for diagnosis of AML..
■ For cases with one of three cytogenetic abnormalities, a diagnosis of AML can
be made with a LOWER BLAST COUNT also :---
1) t (15;17)
2) t (8;21)
3) inversion 16 or t (16;16).
Flow cytometry
b) Oncology
1) DNA content and S phase of tumors
2) Measurement of proliferation markers e.g. Ki-67.
c) Leukemia and lymphoma phenotyping
d) Reticulocyte enumeration
FUNGAL STAIN
2) Gomorri methenamine silver stain ---used for both live and degenerated fungi
and this is best stain for fungi detection...
Laminopathies
(also known as nuclear envelopathies) have a large variety of clinical
symptoms including skeletal and/or cardiac muscular dystrophy,
lipodystrophy and diabetes, dysplasia, dermopathy, neuropathy,
leukodystrophy, and progeria (premature aging).
Most common malignancy after renal transplantation is-----skin (
squamous cell cancer)>>> Non-Hodgkins Lymphoma) >>>>Kaposi
sarcoma.
Biochemical markers that have been correlated with the degree of dementia
in Alzheimer's disease include :
a) Loss of choline acetyltransferase.
b) Synaptophysin Immunoreactivity.
c) Amyloid burden.
Genetic Pregeroid Syndromes
Size of donor and recipient organ doesn’t matter in kidney transplantation.
(Reference---Bailey and Love's short practice of surgery; 26e/page 1413..by
Norman williams...)
Transfusion transmitted hepatitis is most commonly due to "Hepatitis B" infection .
(Harrison 19/e..138e-3).
#Autoimmunity_Mechanism......
C) Pulmonary sarcoidosis.
●●●●●●●●●●●●●●●●●●●●●●●●●●
D) #Clustered_regularly_interspaced_short_palindromic_repeats (CRISPR)-Cas
system
Pancoast tumor is most commonly associated with ----Squamous cell carcinoma
of lung.
Reference__
Thurlbeck's Pathology of the Lung---- By Andrew M. Churg, Jeffrey L. Myers
(page no 449)
HEMATURIA
■ It is considered as biomarker of
1) Intestinal inflammation.
2) colorectal carcinoma.
#Massive_blood_transfusion ......
● Hypokalemia >>>>>Hyperkalemia.........
_______________________________
A) Erythrocyte (RBC ) Counting:
---------------------------------------------------
● In a manual erythrocyte count, 10 µl of EDTA blood (collected with an
Eppendorf pipette) is diluted in 1990 µl of isotonic erythrocyte dilution solution.
● This results in a dilution of 1:200.
● This suspension must be well-mixed and be immediately placed into the
counting chamber.
● After approximately 3 minutes, the erythrocytes will have settled, and one may
begin counting the erythrocytes in 80 small squares.
● The calculation of the erythrocyte count is achieved by following the formula
below using these factors:
1) Number of RBC counted in the small squares.
2) Dilution of the cell solution.
3) Number of counted small squares.
4) Volume above one small square.
5) Conversion factor is necessary in order to arrive at the volume of one liter. Since
we are dealing with one µl, this is equal to 106 (1 µl = 1 x 106 L or 1 L = 1 x 106
µl).
■ #Calculations:
RBC count / µl = {Number of RBC counted × Dilution (200)} ÷ {Number of
squares counted (80) ×volume of 1 small square (0.00025 µl)}
i.e.
RBC count / µl = (Number of RBC counted × 200) ÷ (80) ×0.00025 µl)
i.e.
RBC count / µl = (Number of RBC counted × 200) ÷ (0.02 µl)
● Example with 500 counted RBCs.
RBC count / µl = (Number of RBC counted × 200) ÷ (0.02 µl)
i.e. RBC count / µl = (500 × 200) ÷ (.02 µl) = 5000000 / µl
________________________________________
B) Platelet Counting:
--------------------------------------
● In a platelet count, 50 µl EDTA blood (collected with an Eppendorf pipette) is
mixed in 950 µl dilution solution (collected with an Eppendorf pipette).
● This results in a dilution of 1:20.
● The mixture must stand approximately 5 minutes so that the erythrocytes are
completely lysed.
● Then the suspension is mixed and put into the counting chamber.
● The chamber is left in a moist environment for 20-30 minutes so the platelets can
settle without the chamber drying.
● Like the erythrocyte count, 80 small squares are counted.
● Calculation of the platelet count is achieved by using the formula below using
these factors:
1) Number of platelets counted in the small squares.
2) Dilution of the cell solution.
3) Number of counted squares.
4) Volume above a square.
5) Conversion factor which is necessary in order to come to the volume of one
liter. Since we are moving in the µl area, this is equal to 106 (1 µl = 1 x 106 L or 1
L = 1 x 106 µl).
■ #Calculation:
Platelet counts / µl = Number of platelets counted × Dilution (20) ÷Number of
squares counted (80) ×volume of 1 small square (0.00025 µl)
i.e.
Platelet count / µl = (Number of Platelets counted × 20 ) ÷ (80 × 0.00025 µl)
i.e.
Platelet count / µl = (Number of Platelets counted × 20) ÷ (0.02 µl)
● Example with 200 counted platelets.
Platelet count / µl = (Number of platelets counted × 20) ÷ (.02 µl)
i.e. Platelets count / µl = (200 × 200) ÷ (.02 µl) = 200000 / µl
_________________________________________
C) Leukocyte (WBC ) Counting :
_----------------------------------------------------
● In the manual WBC count, 50 µl of EDTA-blood (collected with an Eppendorf
pipette) is mixed together with 950 µl dilution solution (e.g. Türk's solution,
collected with an Eppendorf pipette).
● This constitutes a dilution of 1:20. The erythrocytes will be lysed, and the
leukocyte nucleus will be stained.
● The counting chamber is immediately filled after mixing. After 2 minutes, one
may begin counting the leukocytes in the 4 large squares.
● Calculation of the leukocyte count is achieved by following the formula below
using these factors:
1) Number of leukocytes counted in the big squares.
2) Dilution of the cell solution
3) Number of counted big squares.
4) Volume above a big square.
5) Conversion factor which is necessary in order to come to the volume of one
liter. Since we are moving in the µl area, this is equal to 106 (1 µl = 1 x 106 L or 1
L = 1 x 106 µl)
■ #Calculations:
WBC count / µl = Number of WBC counted × Dilution (20) ÷Number of squares
counted (4) ×volume of 1 big square (0.1 µl)
i.e.
WBC count / µl = (Number of WBC counted × 20) ÷ (4 × 0.1 µl)
i.e.
WBC count / µl = (Number of WBC counted × 20) ÷ (0.4 µl)
■ Example with 200 counted WBCs.
WBC count / µl = (Number of WBC counted × 20) ÷ (0.4 µl)
= (200 × 20) ÷ (0.4 µl) =10000 / µl
"Molecular classification of breast cancer based on "Gene expression profiling".
■ Transfusion set should have standard filter of 170 micron meter pore size
■ Patient should be monitored during 1st 15 minutes, following this every hour, at
the end and after 4 hrs after end of transfusion.
***************************************
MASSIVE BLOOD TRANSFUSION
**************************************
defined as :-
1) adults
------------------
a) replacement of >1 blood volume in 24 hours ,or
b) >50% of blood volume in 4 hours (adult blood volume is approximately 70
mL/kg).
2) children,
---------------------
● transfusion of >40 mL/kg (blood volume in children over 1 month old is
approximately 80 mL/kg).
● electrolyte abnormalities are :-
1) hypocalcemia
2) hypomagnesemia
3) hypokalemia
4) hyperkalemia
5) metabolic alkalosis ( due to excess citrate is converted to bicarbonate in liver)
■ Bleeding following massive transfusion can occur due to hypothermia, dilutional
coagulopathy, platelet dysfunction, fibrinolysis, or hypofibrinogenemia.
■ Massive bloodTransfusions
Initially TRANSIENT HYPERGLYCEMIA due to glucose in preservatives;
this leads to insulin release and may cause HYPOGLYCEMIA
● Overall most commonly--- HYPOGLYCEMIA > HYPERGLYCEMIA
*************************************
TRALI (Transfusion-Related Acute Lung Injury)
● is the most common cause of major morbidity and death after transfusion. It
presents as an acute respiratory distress syndrome (ARDS) either during or within
6 h of transfusion.
Revised and latest Multiple myeloma diagnostic criteria [ Revised
International Myeloma Working Group (IMWG) ]
● The revised IMWG criteria allow, in addition to the classic CRAB features, three
“myeloma defining events” (MDEs).
● The presence of at least one of these markers is considered sufficient for a
diagnosis of multiple myeloma, regardless of the presence or absence of symptoms
or CRAB features.
● Each of these markers has been associated with an approximately 80% or higher
risk of developing myeloma-related organ damage within two years.
¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤
The new definition of active multiple myeloma is:
¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤
■ Clonal bone marrow plasma cells ≥10% or biopsy-proven bony or
extramedullary plasmacytoma and any one or more of the following CRAB
features and myeloma-defining events:
1) Evidence of end organ damage that can be attributed to the underlying plasma
cell proliferative disorder, specifically:
A) Hypercalcemia: serum calcium >0.25 mmol/L (>1mg/dL) higher than the upper
limit of normal or >2.75 mmol/L (>11mg/dL)
B) Renal insufficiency: creatinine clearance <40 mL per minute or serum
creatinine >177µmol/L (>2mg/dL).
C ) Anemia: hemoglobin valure of >20g/L below the lowest limit of normal, or a
hemoglobin value <100g/L
D)Bone lesions: one or more osteolytic lesion on skeletal radiography, CT, or
PET/CT.
■ If bone marrow has <10% clonal plasma cells, more than one bone lesion is
required to distinguish from solitary plasmacytoma with minimal marrow
involvement.
■ Any one or more of the following biomarkers of malignancy (MDEs ;Myeloma
Defining Events):
1) 60% or greater clonal plasma cells on bone marrow examination.
2) Serum involved / uninvolved free light chain ratio of 100 or greater, provided
the absolute level of the involved light chain is at least 100mg/L (a patient’s
“involved” free light chain—either kappa or lambda—is the one that is above the
normal reference range; the “uninvolved” free light chain is the one that is
typically in, or below, the normal range).
3) More than one focal lesion on MRI that is at least 5mm or greater in size.
LIVER FUNCTION TESTS (LFTS):-
5) BILIRUBIN
*********************
●Normal (0.1–1.0 mg/dL)
● Most commonly used to asses for obstructive jaundice.
● raised in liver damage and in cases of severe RBC damage.
●Test for urobillogen can be useful in determining whether it is due to RBC’s or a
problem with the liver / bile system.
6) ALBUMIN –
*****************
●Normal (3.5 to 5.3 g/dL)
●major protein constituent of plasma, and accounts for over 50% of all plasma
proteins.
●It is manufactured in the liver from ingested amno-acids. It helps to regulate
osmotic pressure as well as transport nutrients and waste products.
●half-life:-
1) albumin ---2 weeks
2) pre-albumin -----2 days
8) 5' NUCLEOTIDASE:
***********************
●specific for cholestasis or damage to the intra or extrahepatic biliary system
●used as a substitute for GGT for ascertaining whether an elevated ALP is of
biliary or extra-biliary origin.
●●●●●●●●●●●●●●●●●●
INTERPRETATIONS:-
●●●●●●●●●●●●●●●●●●
3) Very high ALT, slightly raised AST – suggests viral / drug induced / sever
necrosis of liver
4) ASP raised, ALT slightly raised – suggests alcoholic or drug induced cirrhosis.
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
RATIO OF AST AND ALT CAN BE USEFUL IN DIFFERENTIAL:-
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
TUBERCULOSIS
a) PRIMARY TUBERCULOSIS
●●●●●●●●●●●●●●●●●●●●●●●
■ GHON’S FOCUS:-
**********************
● Subpleural fibrocaseous lesion (CONSOLIDATION) of lung parenchyma.
● microscopically contains epitheloid granulomatous inflammation
■GHON’S COMPLEX:-
**********************
●Consists of Subpleural ghon’s focus and involved lymph nodes.
■RANKE’S COMPLEX :-
***********************
● Ghon’s focus alongwith FIBROSIS and CALCIFICATION known as RANKE’S
COMPLEX.
●Calcification
●Pleural effusion
●Erythema nodosum
● Phlyctenular conjunctivitis
b) POST-PRIMARY
(=SECONDARY)PULMONARY TUBERCULOSIS
●●●●●●●●●●●●●●●●●●●●●●●●●
■PUHL’S LESION:-
********************
● Lesion in lung apex.
● No lymph node involvement
■ SIMON FOCUS
*******************
● it is a tuberculous (TB) nodule formed in lung apex.
● Due to spread of primary TB infection from elsewhere in the body to lung apex
via bloodstream.
● Simon focus nodules are often calcified.
■ ASSMAN FOCUS:-
**********************
●infraclavicular lesion of chronic pulmonary T.B.
● Lymph node involvement is RARE.
secondary TB more likely to cavitate than primary TB.
●Endobronchial spread along nearby airways is relatively common finding,
resulting in relatively well-defined 2-4 mm nodules or branching lesions
TREE-IN-BUD APPEARANCE on CT scan.
■ RICH FOCUS :-
*******************
● It is a tuberculous granuloma occurring on brain cortex that ruptures into
subarachnoid space, causing tuberculous meningitis.
■WEIGERT’S FOCUS :-
*************************
● Subintimal foci in pulmonary vein. ( d/t metastatic caseous TB.)
■ SIMMOND’S FOCUS:-
**********************
● Localized tb foci in liver.
■■■■■■■■■■■■■■■■■■■■
CONGENITAL TUBERCULOSIS:-
■■■■■■■■■■■■■■■■■■■■
● Infection with tubercle bacilli either during intrauterine life or before complete
passage through birth canal is termed as congenital tuberculosis.
● Most common "site" and most common "site of primary complex " both is ---
LIVER ( primary complex in liver is suggestive of congenital TB)
● Prognosis is poor.
A) CLASSICAL—(following 4 subtypes)
******************************************
■ Best / most specific marker for RS cells ---- PAX-5 (>90%...latest info) > CD 30
(80 to 100% of classical HL).
Other markers CD 15 ( 75-85% ).
( Reference-------
Goldman's Cecil Medicine ; page 1229..---
Lee Goldman (MD.), Andrew I. Schafer
Elsevier Health Sciences, 2012 )
1) NODULAR SCLEROSIS.
****************************
• Most common HL (world)
• Mediastinal involvement most common in this HL.
• Male and female are equally affected ( other HL, males are more commonly
affected)
• Lacunar reed Sternberg cells are seen (cytoplasmic lacuna formed due to tissue
fixation artefact )
• “Collagen Bands” are forming nodules in Lymph nodes.
2) MIXED CELLULARITY
**************************
• Most common HL in India
• Maximum RS cells are seen.
3) LYMPHOCYTE DEPLETED.
*******************************
• Least common type of HL
• RS cells (various names) ---pleomorphic / Mummified / necrobiotic
• Worst prognosis
4) LYMPHOCYTE RICH
**************************
• Minimum RS cells are seen.
B) LYMPHOCYTE PREDOMINANT:-
***********************************
■ EBV and HIV infections ,both are most commonly a/w(amongst Hodgkins
lymphoma subtype)----MIXED CELLULARITY (HODGKINS LYMPHOMA)
1) HEMATOXYLIN stain:
------------------------------------------
#Blue and basic
2) EOSIN :
------------------
#Pink and acidic.
#Cytoplasm is stained.
a) Sudan black B
b) Sudan IV
c) Annexin V
d) Osmium teroxide
4) PAS Stain :
------------------------
a) Glycogen
b) Fungus and amoeba
c) Basement membrane
d) Lymphoblast (BLOCK LIKE POSITIVITY)
e) Erythroblast (DIFFUSELY POSITIVE)
5) CALCIUM STAINS :
------------------------------------
a) Von kossa
b) Alizarin red
c) Calcein
7) FUNGUS STAINS:
---------------------------------
a) Gomori’s methenamine silver stains ---(best fungal stain; stains both live and
dead fungus)
8) AMYLOID STAINS:
------------------------------------
a) Lugol’s iodine—gross specimen
b) Hematoxylin and eosin
c) Methyl violet
d) Crystal violet
e) Thioflavin T
f) Toluidine blue
g) PAS
h) Alcian blue
i) CONGO RED STAIN--- pink/red under ordinary light
And APPLE –GREEN BIREFRINGERENCE on POLARISED
MICROSCOPY(DIAGNOSTIC)
1) Incidence---Lung cancer
2)Mortality---Lung cancer
B)FEMALE
1)Incidence----Breast ca
2)Mortality----Breast cancer
C) OVERALL
● Most common incidence and mortality both---Lung cancer
■■■■■■■■■
INDIA
■■■■■■■■■
B)FEMALE
● Incidence and mortality both --Breast cancer
C) OVERALL
● mortality and incidence both--Breast cancer
THROMBOELASTOGRAPHY (TEG)
■ fatal syndrome that has detrimental effects to organs, especially the brain and
liver
● elevated liver enzymes, elevated ammonia levels, and low serum glucose levels.
■ HISTOLOGIC CHANGES:-
----------------------------'-----------------
● All cells have pleomorphic, swollen mitochondria that are reduced in number (
diagnostic finding)
● Liver --- fatty liver with minimal inflammation (Microvesicular Steatosis ) and
glycogen depletion.
■ In Cirrhotic liver---- Collagen Type 1 and 3 both are present at space of disse.
CHROMOTHRYPSIS:
Means chromosome shattering; a/k/a dramatic chromosome catastrophe)
1)seen in OSTEOSARCOMAS(other bone cancers too) and GLIOMAS.
2) dozens to hundreds of chromosomal breaks occurs in single or several
chromosomes,then they are repaired haphazardly
3)this will activate Oncogenes and inactivate Tumor suppressor gene.
4)its mechanism of carcinogenesis.
#Pseudolymphoma
------------------------------------
•to detect deletions and duplications of any size (it includes size that are too
large to be detected by PCR and too small to be amplified by FISH)
•example is CYSTIC FIBROSIS ( it can detect deletion of each of the 27 exons
of CFTR gene)
CARCINOID -TUMORLETS :-
TUMORLET :-
#defined as hyperplasia of neuroendocrine cells that are 5 mm or less in size
and lack of mitotic activity and necrosis.
CYSTIC FIBROSIS
■ Autosomal recessive.
■Chromosome 7q.
Ref :-
-----------
1) Oxford textbook of Medicine vol.1 page no 415.
References:
--------------------
1) Brenner and Rector' the kidney pg no.851.
a) in children--- monosomy 7
b) adults---5q- (deletion)
c) overall ---5q- (deletion)
References:
Reference:-
A) Kaposi sarcoma
B) Non-Hodgkin lymphoma, and
C) Cervical cancer.
■ A diagnosis of any one of these cancers marks the point at which HIV
infection has progressed to AIDS.
Plasmodium species :
☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆
1) HBsAg—
¤¤¤¤¤¤¤¤¤¤¤¤¤
2) anti-HBs—
¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤
● Implies either active or passive immunization that usually persists for life.
● Protected.
3) Anti-HBc—
¤¤¤¤¤¤¤¤¤¤¤¤¤
● IgM anti-HBc indicates acute infection.( most reliable and earliest marker
of acute hepatitis infection).
4) HbeAg:-
¤¤¤¤¤¤¤¤¤¤¤
● High infectivity and active disease.
5) anti-HBe:
¤¤¤¤¤¤¤¤¤¤¤¤¤¤
●●●●●●●●●●●●●●●●●●●●●●●●●
● Refers to HBeAg-negative with normal serum ALT levels and low (<
2000 IU/mL) or undetectable HBV DNA.
● It indicates late stage of carrier and they will transmit infection when large
quantities of blood are transferred.
Reference:-
Diagnostic Immunohistochemistry by David J Dabbs - Page 616.
¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤
■ Forward grouping :-
● Tests the recipient or donor red cells with anti-A and anti-B sera.
#interpreations are:
¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤
■ Reverse grouping:-
¤ tests the serum/plasma from the recipient or donor with group A red cells
and group B red cells
#Interpretations :-
4) Agglutination with group A cells and group B cells both indicates the
presence of anti-A in and anti-B both in the plasma – Group O individual.
● #Adults
☆☆☆☆☆☆☆☆
● #Pediatrics:-
☆☆☆☆☆☆☆☆☆☆☆☆
Most common malignancy ----------Mucoepidermoid carcinoma> Acinic cell
carcinoma
☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆
● Salivary gland tumor more commonly seen in males ------ Warthins tumour.
● Major inducers of acute phase proteins are IL1, IL6, and TNF.
● Two mediators IL1 and IL6 have been used to classify acute phase proteins into
two subgroups.
■ They are those that require IL6 only for maximal induction.
Interleukins
● IL4 ------
¤ Produced by TH2 cells (blocks proliferation of TH1 cells along with IL10).
¤ Associated with IgE class switch ( similar to IL13)
● IL6 -----
■ Allergic Bronchopulmonary Mycoses (ABPM) will have all these types of HSR:
#Gene_Knock_in
#Gene_Knock_out
#Gene_knock_down
●●●●●●●●●●●●●●●●●●●●
A) Gene Knockin:-
¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤
■ This technique alters the genetic locus of interest by a one-for-one substitution of
DNA sequence information or by the addition of sequence information that is not
found on said genetic locus.
■ A “gene knockin” can be seen as a “gain “of function mutation and a “gene
knockout “a “loss” of function mutation.
B) Gene knockout :-
¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤
C) Gene knockdown :-
¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤
■ The reduction can occur either through genetic modification or by treatment with
a reagent such as a short DNA or RNA oligonucleotide that has a sequence
complementary to either gene or an mRNA transcript (e.g. by small interfering
RNA (siRNA).
■ It is used for learning about a gene that has been sequenced, but has an unknown
or incompletely known function.
( It contains about 249 million DNA building blocks (base pairs) and representing
approximately 8 percent of the total DNA in cells.)
1) Cystatin c
4) Alpha1 microglobulin
7) Interleukin18.
8) osteopontin,
9) clusterin,
#Harrison_19e_update
Factors controlling the regulation of gene and protein expression that change with
aging.
The expression of miRNAs usually decreases with aging and is altered in some
age-related diseases.
■ Specific miRNAs linked with aging pathways include miR-21 (associated with
target of rapamycin pathway) and miR-1 (associated with insulin/insulin-like
growth factor 1 pathway).
#Harrison_19e(pg.2612)
● Mechanism:
It is not known precisely.
GBA mutations are associated with altered autophagy and lysosomal function and
could impair clearance of αlpha-synuclein.
Diabetes Ketoacidosis vs Hyperglycemic Hyperosmolar State (HHS).
#Harrison19e
☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆
NECROPTOSIS:
● Necroptosis differs from Apoptosis by following features (that’s why they are
considered as NECROSIS ---- “Caspase independent programmed cell death” )
Chédiak-Higashi syndrome
___________________________
● Autosomal recessive.
● Disordered coalescence of lysosomal granules Responsible gene found at
1q42-45. The encoded protein (LYST) has structural features homologous to a
vacuolar sorting protein.
● Clinical features :
a) Neutropenia, recurrent pyogenic infections.
b) Propensity for the development of marked hepatosplenomegaly in the
accelerated phase.
c) Partial albinism:
d) Defects in myelopoiesis result in neutropenia.
e) Advanced disease is characterized by lymphocytic tissue infiltrates and
pancytopenia.